跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OLMESARTAN/HIDROCLOROTIAZIDA RATIOPHARM 40MG/25MG COMPRIMIDO RECUBIERTO CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OLMESARTAN/HIDROCLOROTIAZIDA RATIOPHARM 40MG/25MG COMPRIMIDO RECUBIERTO CON PELICULA EFG
Approved
STANDARD
OLMESARTAN/HIDROCLOROTIAZIDA RATIOPHARM 40MG/25MG COMPRIMIDO RECUBIERTO CON PELICULA EFG
Ratiopharm Espana S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 5, 2022
Approval ID
831b0fede37d3fb3
Company
Ratiopharm Espana S.A.
Type
Standard
Approval Details
Approval Id
831b0fede37d3fb3
Drug Cima Aemps Name
OLMESARTAN/HIDROCLOROTIAZIDA RATIOPHARM 40MG/25MG COMPRIMIDO RECUBIERTO CON PELICULA EFG
Register Number
86761
Holder Company Name
Ratiopharm Espana S.A.
Marketing Company Name
Ratiopharm Espana S.A.
Authorization Date
2022-04-05
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40 mg/25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Ratiopharm Espana S.A.
Active Ingredients
OLMESARTAN MEDOXOMILO
40 mg
HIDROCLOROTIAZIDA
25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 5, 2022
Approval ID
831b0fede37d3fb3
Type
Standard
Back to CIMA-AEMPS Approvals